Journal
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
Volume 107, Issue 1, Pages -Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/jnci/dju384
Keywords
-
Categories
Funding
- National Institutes of Health
- National Human Genome Research Institute, Bethesda, Maryland [R01CA119215, R01CA070917, R01CA52689, P50097257, R01CA126831, U54HG003273, P30CA125123, K23CA 158148, 5 R01CA138836, 5 P30 CA125123]
- McNair Medical Institute
- Population Sciences Biorespository at Baylor College of Medicine
- American Brain Tumor Association
- St. Baldrick's Foundation
- National Brain Tumor Society
Ask authors/readers for more resources
Gliomas are the most common brain tumor, with several histological subtypes of various malignancy grade. The genetic contribution to familial glioma is not well understood. Using whole exome sequencing of 90 individuals from 55 families, we identified two families with mutations in POT1 (p.G95C, p.E450X), a member of the telomere shelterin complex, shared by both affected individuals in each family and predicted to impact DNA binding and TPP1 binding, respectively. Validation in a separate cohort of 264 individuals from 246 families identified an additional mutation in POT1 (p.D617Efs), also predicted to disrupt TPP1 binding. All families with POT1 mutations had affected members with oligodendroglioma, a specific subtype of glioma more sensitive to irradiation. These findings are important for understanding the origin of glioma and could have importance for the future diagnostics and treatment of glioma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available